Rentokil Initial Plc SEC Filings

Rentokil Initial plc held its 2026 Annual General Meeting on 7 May 2026, where all 23 resolutions were passed on a poll. Shareholder turnout was high, with around 86% of the issued share capital voting.

Shareholders strongly backed the audited financial statements, with 2,158,322,403 votes for (99.45%), and approved the final dividend with 2,165,477,509 votes for (99.62%). The Directors' Remuneration Report received 92.27% support. All directors standing for election or re-election were endorsed, generally with more than 96% of votes cast in favour, except one re-election that still passed with a clear majority.

Investors also renewed key capital authorities, including the power to allot shares and to make market purchases of the company’s own shares, and approved resolutions to disapply statutory pre-emption rights, with the resolution relating to acquisitions and specified capital investments receiving 86.36% support. The total number of ordinary shares in issue at close of business on 6 May 2026 was 2,526,039,885.

BlackRock Portfolio Management LLC amends a Schedule 13G to report beneficial ownership of 175,098,972 shares of Rentokil Initial plc common stock, representing 6.9% of the class. The filing shows sole voting power for 162,993,738 shares and sole dispositive power for 175,098,972 shares.

The amendment is signed by a BlackRock managing director and reflects holdings reported by certain BlackRock business units under SEC Release No. 34-39538.

Rentokil Initial plc has set the sterling amount for its previously announced final dividend for the year ending 31 December 2025 at 6.10 pence per ordinary share. The dividend was originally declared as 8.24 cents per share, and the conversion uses an exchange rate of GBP1:USD1.3513 based on the average closing spot rates over three working days starting 20 April 2026.

The final dividend remains subject to shareholder approval at the Annual General Meeting on 7 May 2026. If approved, it will be paid on 18 May 2026 to shareholders on the register at the close of business on 10 April 2026.

Rentokil Initial plc, through wholly owned subsidiary Rentokil Terminix Funding plc, has issued senior, unsecured $500 million 4.625% Notes due 2031, guaranteed by the Company. The notes were offered to qualified institutional buyers under Rule 144A and outside the U.S. under Regulation S.

The Company intends to use the net proceeds for general corporate purposes, including debt repayment. Application has been made to list and trade the notes on the Official List and Global Exchange Market of Euronext Dublin.

Rentokil Initial plc reports a TR‑1 notification of major holdings from BlackRock, Inc.. BlackRock’s total holding in Rentokil Initial now represents 13.000000% of voting rights, up from 12.510000% at the previous notification, corresponding to 328889348 voting rights held in the issuer.

The position is split between voting rights attached to shares and financial instruments. Shares carry 263877846 voting rights, equal to 10.440000%. Financial instruments provide an additional 2.560000% of voting rights, including American Depository Receipts and securities lending arrangements, as well as contracts for difference and equity‑linked notes.

Rentokil Initial plc reported first-quarter 2026 revenue of $1,677m, up 4.3% at constant currency with 3.4% Organic Revenue growth. Management described this as a good start in a seasonally quieter period and expressed confidence in delivering a full-year performance in line with market expectations.

North America generated revenue of $995m, up 4.5%, with Pest Control growing organically by 4.1% and strong 12.7% Organic Revenue growth in Business Services helped by pre-spring demand and prior-year contract wins. International revenue was $682m, up 4.1%, with good growth in Europe, Latin America and the UK & Sub-Saharan Africa, partly offset by softer trends in Pacific and MENAT.

By category, Pest Control delivered 3.7% Organic Revenue growth, while Hygiene & Wellbeing grew 2.1% overall, including a decline of (2.7)% organically in North America due to later construction-related revenue. The Group completed 9 bolt-on acquisitions with prior-year annualised revenue of $19m, continuing its M&A-led expansion strategy.

Rentokil Initial plc has appointed Thérèse Esperdy as Chair of the Board, effective 1 September 2026. She will first join as a Non-Executive Director and Chair-designate on 1 July 2026, supporting an orderly transition.

Esperdy currently serves as Non-Executive Chair of Imperial Brands and holds senior roles at Smith & Nephew and Moody's, with a long executive background at JP Morgan. She will receive total fees of £725,000 per annum. Current Chair Richard Solomons, who has led the Board since 2019, will retire from the Board at midnight on 31 August 2026. The Board has determined Esperdy to be independent under the Corporate Governance Code.

Rentokil Initial plc has reported a change in a major shareholding by BlackRock, Inc.. BlackRock now holds a total of 12.51% of Rentokil Initial’s voting rights, equivalent to 316,885,253 voting rights.

The position consists of 10.05% of voting rights attached to ordinary shares and a further 2.46% held through financial instruments such as American Depositary Receipts, securities lending and derivatives. The total stake increased slightly from a previously notified 12.33%, indicating a modest rise in BlackRock’s exposure to the company.

Rentokil Initial plc reported that its Chair, Richard Solomons, who is classified as a Person Discharging Managerial Responsibility, bought additional shares in the company. On 26 March 2026, he purchased 21,100 ordinary shares at a price of £4.635902 per share, for a total consideration of £97,817.53. The transaction involved ordinary shares of 1p each, traded on the London Stock Exchange (XLON), and was disclosed in line with Article 19 of the UK Market Abuse Regulation.